Dr. Benítez-Páez is a Biologist with postgraduate degrees M.Sc in Biochemistry and Sp. in Biotechnology. His PhD in Molecular Biology was gained at the UAM in Madrid, Spain. During his PhD, he worked in the analysis of the enzyme-dependent post-transcriptional modifications in bacterial rRNA and tRNA. He remained at FISBABIO-CSISP (Valencia, Spain) for his first post-doc, studying the human oral microbiome and the characterization of probiotics for oral health. Since 2014, he is involved in the MyNewGut project funded by the European Commission working in the development of dietary-based strategies to tackle XXI century pandemics such as obesity and co-morbidities at the Institute of Agrochemistry and Food Technology (IATA-CSIC) in Valencia, Spain. Dr. Benítez-Páez is currently coordinating metagenome analyses of dietary interventions in humans aiming the functional characterization of diet compounds able to modulate the human gut microbiota towards a healthy status. His research continues to focus on the development of new molecular approaches for the deep characterization of microbial communities, aiming the identification at species and strain level for direct association of gut microbes with health and disease as well as characterization of predictive biomarkers of disease in the gut microbiome components.
About his talk:
"Multi-omics assessment of AXOS intake in overweight people with signs of metabolic syndrome"
- There is contradictory data regarding the effect of AXOS dietary interventions on improving of glucose and lipid metabolism in overweight/obese subjects.
- Cutting-edge omics technologies demonstrated the positive impact of AXOS in human health despite its apparently null effect on anthropometry and physiology.
- Omics data integration suggest that AXOS intake does exert a positive impact on glucose homeostasis in different ways.